LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

Helene Lindfors, Ph.D. Student at the Endocrine Surgery research group, the Department of Molecular Medicine and Surgery, ...

CLO equity feels pressure from rising risks, but cash flows remain strong. Explore strategies like CEF rotation or CLO debt ...

Renowned author Siddharth Dhanvant Shanghvi discusses the importance of editing in publishing, reminiscing over his journey ...